关注
Sandip chavhan
Sandip chavhan
Principal Scientist, Glenmark Pharmaceuticals Limited
在 glenmarkpharma.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies
SA Joshi, SS Chavhan, KK Sawant
European journal of pharmaceutics and biopharmaceutics 76 (2), 189-199, 2010
2962010
Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation
S Gupta, S Chavhan, KK Sawant
Colloids and surfaces A: physicochemical and engineering aspects 392 (1 …, 2011
2472011
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route
S Patel, S Chavhan, H Soni, AK Babbar, R Mathur, AK Mishra, K Sawant
Journal of drug targeting 19 (6), 468-474, 2011
1952011
Nanostructured materials in drug and gene delivery: a review of the state of the art
KC Petkar, SS Chavhan, S Agatonovik-Kustrin, K Sawant
Critical Reviews™ in Therapeutic Drug Carrier Systems 28 (2), 2011
1452011
Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study
C Detroja, S Chavhan, K Sawant
Scientia pharmaceutica 79 (3), 635-652, 2011
1032011
An overview of nanocarrier-based adjuvants for vaccine delivery
KC Petkar, SM Patil, SS Chavhan, K Kaneko, KK Sawant, NK Kunda, ...
Pharmaceutics 13 (4), 455, 2021
712021
Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies
SS Dodiya, SS Chavhan, KK Sawant, AG Korde
Journal of microencapsulation 28 (6), 515-527, 2011
602011
Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects
SS Chavhan, KC Petkar, K Sawant
Critical Reviews™ in Therapeutic Drug Carrier Systems 28 (5), 2011
592011
Development of novel octanoyl chitosan nanoparticles for improved rifampicin pulmonary delivery: optimization by factorial design
KC Petkar, S Chavhan, N Kunda, I Saleem, S Somavarapu, KMG Taylor, ...
AAPS PharmSciTech 19, 1758-1772, 2018
582018
Solid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studies
S Dodiya, S Chavhan, A Korde, KK Sawant
Drug development and industrial pharmacy 39 (5), 733-743, 2013
382013
Enhanced bioavailability and hypolipidemic activity of Simvastatin formulations by particle size engineering: Physicochemical aspects and in vivo investigations
S Chavhan, G Joshi, K Petkar, K Sawant
Biochemical engineering journal 79, 221-229, 2013
242013
Simvastatin nanoemulsion for improved oral delivery: design, characterisation, in vitro and in vivo studies
SS Chavhan, KC Petkar, KK Sawant
Journal of microencapsulation 30 (8), 771-779, 2013
222013
Design and evaluation of once daily sustained release matrix tablets of nicorandil
S Chavhan, S Anantwar, D Derle
International journal of pharmacy and pharmaceutical sciences 3 (2), 13-18, 2011
212011
A Comparative In vitro Evaluation of Transdermal Permeation of Valdecoxib and its Complex with HP-beta-Cyclodextrin from Microemulsion Based Gel
DV Derle, BSH Sagar, RS Kotwal, RD Ingole, SS Chavhan
INDIAN DRUGS-BOMBAY- 43 (8), 625, 2006
172006
Nanonising approaches in drug delivery
S Chavhan, KS Kailash Petkar
Handbook of clinical Nanomedicine: Nanoparticles, imerging therapy and …, 2016
12016
Formulation and evaluation of nanosized drug formulations as novel delivery system for drugs with low bioava bioavailability lability
SS Chavhan
Gujarat, 0
Critical Reviews™ in Therapeutic Drug Carrier Systems
KC Petkar, SS Chavhan, S Agatonovik-Kustrin, KK Sawant
Formulation and evaluation of nanosized drug formulations as novel delivery system for drugs with low bioavalability
SS Chavhan
Gujarat, 0
系统目前无法执行此操作,请稍后再试。
文章 1–18